Property | Value |
?:abstract
|
-
Spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2-SP, SARS-CoV-2-NP) are the main immunogenic targets for antibodies. We herein demonstrate that the glycosylation of SARS-CoV-2-NP masks some of its antibody epitopes. In many cases, this can lead to false-negative serological tests. Deglycosylation of SARS-CoV-2-NP significantly increased the number of positive tests. The glycosylation pattern analysis of this protein revealed that the putative N-linked glycosylation sites, at the amino acid positions 48 and 270, co-located with two of the main immunodominant B cell epitopes.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
-
10.1016/j.bbrc.2020.11.060
|
?:doi
|
|
?:journal
|
-
Biochem_Biophys_Res_Commun
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/9cee86b075ccec62c051538188bddc2ec4e133f5.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7678427.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation
|
?:type
|
|
?:year
|
|